trial · primary record
Delamanid (DLM)
Tuberculosis, MDR
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 5832 |
| Primary completion | 2026-11-16 |
| Primary endpoint | Percent of participants with confirmed or probable active TB at any time between Day 0 and the week 96 study visit |
| Registry ID | NCT03568383 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:58.917Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03568383
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.